11
Growth Score
pts
Heat Score
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1375345
Personalized genomic risk assessments for proactive health.
About the Company
GenomicMD, launched in 2023, is a healthcare company dedicated to integrating genomic-based personalized medicine into clinical practice. Their core offering is the Lifetime Genomics Risk Assessment (LGRA), a polygenic screening test providing insights into an individual's unique genomic risks for common diseases like cancer and heart disease.
GenomicMD empowers physicians to use this data for proactive prevention, earlier detection, and personalized patient management. They believe their evidence-based methods identify significantly more at-risk individuals than traditional screenings. GenomicMD is committed to health equity and expanding the adoption of polygenic risk scoring through partnerships with healthcare providers.
